2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Belatacept Based Immunosuppression and Incidence of Proteinuria in Kidney Transplant Recipients

R. Villicana, A. Peng, J. Kahwaji, J. Choi, A. Vo, S. Jordan.
Belatacept in a Community Hospital Adult Kidney Transplant Program

D. Nikolaenko, Q. Chaudhry, H. Smith, C. Shadur.
Belatacept Treatment Through Home Infusion as a Safe and Reasonable Alternative to Intitution-Based Treatment: A Retrospective Analysis of Medical Records

T. Kou,¹ A. Deshmukh,¹ J. Preston,¹ A. Gomez,¹ S. Rafanelli,² K. Calderon.¹
Belatacept-Treated Patients Had Better Graft Survival at 7-Years Post-Transplant Compared With Cyclosporine-Treated Patients: Final Results from BENEFIT

F. Vincenti,¹ J. Grinyó,² L. Rostaing,³ K. Rice,⁴ S. Steinberg,⁵ M. Moal,⁶ M. Polinsky,⁷ U. Meier-Kriesche,⁷ C. Larsen.⁸
Beneficial Effects of Controlling Peritransplant Inflammation in Total Pancreatectomy With Islet Autotransplantation: A Single Center Experience With Large Cohort of Patients

M. Takita,¹ M. Kanak,² R. Shahbazov,¹ G. Yoshimatsu,¹ M. Lawrence,¹ A. Dabous,³ P. Kim,³ N. Onaca,³ B. Naziruddin,³ M. Levy.³
Bidirectional Regulation and IL35 Surface Expression By Treg Cells

Y. Tomita, W. Burlingham.
Biliary Complication After Living Donor Liver Transplantation According to Biliary Reconstruction Methods

J. Lee,^1,2 J. Lee,^1,2 D. Han,^1,2 J. Lee,³ M. Ju,^1,2 M. Kim,^1,2 G. Choi,^1,2 J. Choi,^1,2 S. Kim,^1,2 D. Joo.^1,2
Bioengineering Liver Allografts through Organ Scaffold Recellularization

J. Woodall, J. Langford, C. Klassen, J. Harrison, D. Parsell, U. Dhru, R. Barth, J. LaMattina.
Biomarker for Calcineurin Inhibitors Nephrotoxicity in Solid Organ Transplantation: Validation of a Urine Gene Expression Panel

D. Maluf, R. Gehrau, J. Suh, K. Brayman, C. Bustamante, M. Edmunds, P. Darvishi, V. Mas.
Biomarker Panel Profile for Identification of High-Risk Patients After Heart Transplantation

M. Barten,¹ M.-T. Dieterlen,² J. Garbade,² F. Mohr.²

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z